Home - Business - AbbVie's Humira Downfall Is Swift As Biosimilars Hammer Away At SalesAbbVie's Humira Downfall Is Swift As Biosimilars Hammer Away At SalesBusiness2023-04-28 AbbVie stock crumbled Thursday after the first biosimilar to launch in the U.S. hammered away at Humira’s legendary sales. Continue reading